|
|
|
Volumn 18, Issue 14 Suppl 11, 2004, Pages 4-13
|
|
Discovery, Development, and clinical applications of bortezomib.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
PROTEASOME;
PROTEINASE INHIBITOR;
PYRAZINE DERIVATIVE;
ANIMAL;
CELL CYCLE;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
HUMAN;
MULTIPLE MYELOMA;
NONHODGKIN LYMPHOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
TIME;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CELL CYCLE;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MULTIPLE MYELOMA;
PROTEASE INHIBITORS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PYRAZINES;
TIME FACTORS;
|
|
EID: 17644408423
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (61)
|
